Tiverton Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $2.3M | Buy |
23,837
+2,853
| +14% | +$275K | 0.08% | 192 |
|
|
2019
Q2 | $2.42M | Buy |
20,984
+1,389
| +7% | +$160K | 0.09% | 181 |
|
|
2019
Q1 | $2.31M | Sell |
19,595
-7,128
| -27% | -$839K | 0.1% | 162 |
|
|
2018
Q4 | $1.67M | Sell |
26,723
-18,993
| -42% | -$1.19M | 0.1% | 134 |
|
|
2018
Q3 | $3.24M | Buy |
45,716
+1,877
| +4% | +$133K | 0.16% | 107 |
|
|
2018
Q2 | $2.92M | Buy |
43,839
+1,695
| +4% | +$113K | 0.15% | 116 |
|
|
2018
Q1 | $2.76M | Buy |
+42,144
| New | +$2.76M | 0.19% | 104 |
|